Etamiphylline
Appearance
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name
7-[2-(Diethylamino)ethyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.005.678 |
KEGG | |
PubChemCID
|
|
UNII | |
CompTox Dashboard(EPA)
|
|
| |
| |
Properties | |
C13H21N5O2 | |
Molar mass | 279.33814 |
Pharmacology | |
R03DA06(WHO) | |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
|
Etamiphyllineoretamiphyllin(INN)[1]is axanthineintended for use as an anti-asthmaagent. It has shown poor to absent effects in human clinical trials.[2][3]
References[edit]
- ^"International Non-Proprietary Names for Pharmaceutical Preparations. Recommended International Non-Proprietary Names (Rec. I.N.N.): List 3"(PDF).World Health Organization. p. 467.Retrieved29 December2016.
- ^Vazquez, C; Labayru, T; Rodriguez-Soriano, J (1984). "Poor bronchodilator effect of oral etamiphylline in asthmatic children".Lancet.1(8382): 914.doi:10.1016/s0140-6736(84)91380-1.PMID6143224.
- ^Addis, GJ (1984). "Absence of bronchodilatory effect from etamiphylline".Lancet.1(8385): 1083.doi:10.1016/s0140-6736(84)91497-1.PMID6144017.